|
|
|
|
| LEADER |
03471nam a2200589 4500 |
| 001 |
ocn941134263 |
| 003 |
OCoLC |
| 005 |
20180501122029.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
160226s2016 maua ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d UIU
|d YDXCP
|d OPELS
|d N$T
|d CDX
|d IDEBK
|d EBLCP
|d OCLCF
|d SDB
|d UAB
|d OCLCQ
|d CASUM
|d OCLCO
|d MEU
|d NLE
|d GrThAP
|
| 019 |
|
|
|a 942843953
|a 948792407
|a 1011182596
|
| 020 |
|
|
|a 9780128024836
|q electronic bk.
|
| 020 |
|
|
|a 0128024836
|q electronic bk.
|
| 020 |
|
|
|a 9780128022900
|q print
|
| 020 |
|
|
|a 0128022906
|
| 035 |
|
|
|a (OCoLC)941134263
|z (OCoLC)942843953
|z (OCoLC)948792407
|z (OCoLC)1011182596
|
| 050 |
|
4 |
|a RC267
|b .H77 2016eb
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99/4071
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Hsp90 in Cancer :
|b Beyond the Usual Suspects /
|c edited by Jennifer Isaacs and Luke Whitesell.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Academic Press is an imprint of Elsevier,
|c 2016.
|
| 300 |
|
|
|a 1 online resource (xv, 257 pages :
|b illustrations (some color)).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in cancer research ;
|v 129
|
| 546 |
|
|
|a Text in English.
|
| 505 |
0 |
|
|a Unusual suspects in the twilight zone between the Hsp90 interactome and carcinogenesis / Evangelia Vartholomaiou, Pablo C. Echeverría and Didier Picard -- Impact of posttranslational modifications on the anticancer activity of Hsp90 inhibitors / Mark R. Woodford, Diana Dunn, Jonelle B. Miller, Sami Jamal, Len Neckers and Mehdi Mollapour -- Anticancer inhibitors of Hsp90 function: beyond the usual suspects / Gaurav Garg, Anuj Khandelwal and Brian S. J. Blagg -- HSP90 in cancer: transcriptional roles in the nucleus / Stuart K. Calderwood and Len Neckers -- Hsp90 as a 'chaperone' of the epigenome: insights and opportunities for cancer therapy / Jennifer S. Isaacs -- Emerging roles of extracellular Hsp90 in cancer / Daniel Senh Wong and Daniel G. Jay -- GRP94/gp96 in cancer: biology, structure, immunology and drug development / Bill X Wu, Feng Hong, Yongliang Zhang, Ephraim Ansa-Addo and Zihai Li -- HSP90 and immune modulation in cancer / Michael W. Graner -- Hsp90: a global regulator of the genotype-to-phenotype map in cancers / Daniel Jarosz.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed March 3, 2016).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Molecular chaperones.
|
| 650 |
|
0 |
|a Carcinogenesis
|x Molecular aspects.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Carcinogenesis
|x Molecular aspects.
|2 fast
|0 (OCoLC)fst00846978
|
| 650 |
|
7 |
|a Molecular chaperones.
|2 fast
|0 (OCoLC)fst01024760
|
| 650 |
1 |
2 |
|a Molecular Chaperones.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Isaacs, Jennifer
|c (Professor of Pharmacology),
|e editor.
|
| 700 |
1 |
|
|a Whitesell, Luke,
|e editor.
|
| 830 |
|
0 |
|a Advances in cancer research ;
|v 129.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/0065230X/129
|z Full Text via HEAL-Link
|
